Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|October 1, 1989
Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitroR J Riley, N R Kitteringham, B K Park
Toxicology and Applied Pharmacology|November 1, 1995
Expression and inducibility of antigens in severe combined immunodeficient mice recognized by human anti-P450 antibodiesR S Rajasenan, R J Riley, J S Leeder
The Journal of Pharmacy and Pharmacology|April 1, 1993
A comparative study of the toxicity of chemically reactive xenobiotics towards adherent cell cultures: selective attenuation of menadione toxicity by buthionine sulphoximine pretreatmentR J Riley, S P Spielberg, J S Leeder
Archives of Dermatology|July 1, 1984
Bypass phrynoderma. Vitamin A deficiency associated with bowel-bypass surgeryD J Barr, R J Riley, D J Greco
Biochemical Pharmacology|July 15, 1991
Glutathione transferase mu deficiency is not a marker for predisposition to sulphonamide toxicityR J Riley, A E Cribb, S P Spielberg
Pharmacology & Therapeutics|January 1, 1991
Drug metabolism in carcinogenesis and cancer chemotherapyM A Graham, R J Riley, D J Kerr
British Journal of Clinical Pharmacology|June 1, 1989
A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitroR J Riley, C Lambert, N R Kitteringham, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450sD F McGinnity, A J Parker, M Soars, et al.
Carcinogenesis|August 1, 1994
Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductaseS A Fitzsimmons, A D Lewis, R J Riley, et al.
Biochemical Pharmacology|March 9, 1993
Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075)R J Riley, S A Hemingway, M A Graham, et al.
Pageof 5